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Abstract
Background: Knowledge translation (KT) is a buzzword in modern medical science. However, there has been little
theoretical reflection on translation as a process of meaning production in KT. In this paper, we argue that KT will
benefit from the incorporation of a more theoretical notion of translation as an entangled material, textual and
cultural process.
Discussion: We discuss and challenge fundamental assumptions in KT, drawing on theories of translation from the
human sciences. We show that the current construal of KT as separate from and secondary to the original scientific
message is close to the now deeply compromised literary view of translation as the simple act of copying the
original. Inspired by recent theories of translation, we claim that KT can be more adequately understood in terms of
a ‘double supplement’ – on the one hand, KT offers new approaches to the communication of scientific knowledge
to different groups in the healthcare system with the aim of supplementing a lack of knowledge among clinicians
(and patients). On the other, it demonstrates that a textual and cultural supplement, namely a concern with target
audiences (clinicians and patients), is inevitable in the creation of an ‘autonomous’ science. Hence, the division
between science and its translation is unproductive and impossible to maintain. We discuss some possible
implications of our suggested shift in concept by drawing on pharmaceutical interventions for the prevention of
HIV as a case. We argue that such interventions are based on a supplementary and paradoxical relation to the
target audiences, both presupposing and denying their existence.
Summary: More sophisticated theories of translation can lay the foundation for an expanded model of KT that
incorporates a more adequate and reflective description of the interdependency of scientific, cultural, textual and
material practices.
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Background
Several articles in BMC journals have recently drawn
attention to fundamental concepts within evidence-
based medicine and knowledge translation (KT) [1–4].
Greenhalgh et al. [3] have questioned the dominant no-
tion of evidence in evidence-based medicine by drawing
attention to six biases’ against patients and care givers.
Kelly et al. [1] have emphasised the often underesti-
mated role of values in evidence-based decision making.
More recently, Greenhalgh et al. [4] have explored the
notion of research impact and its philosophical basis.
We will add to this debate by challenging and expanding
the metaphor of KT; we are aware that we are not the
first to challenge this metaphor [5]. However, while
other authors have mainly questioned the knowledge
aspect of the concept, we are more interested in what
the term ‘translation’ has to offer and how it might be
expanded.
The term ‘translation’ has become increasingly import-
ant in the contemporary natural and human sciences.
On the one hand, the turn to translation can be traced
across a number of human sciences, such as cultural
history, anthropology, and science and technology stud-
ies [6]. On the other hand, translation has lately become
institutionalised in the field of medicine, leading to the
development of ‘knowledge translation’ and ‘transla-
tional research’. These concepts refer to a set of research
activities bound together by the common goal of
* Correspondence: eivind.engebretsen@medisin.uio.no
1Institute of Health and Society, Faculty of Medicine, University of Oslo, BOX
1130, Blindern 0318, Oslo, Norway
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Engebretsen et al. Health Research Policy and Systems  (2017) 15:19 
DOI 10.1186/s12961-017-0184-x
‘bridging the gap’ between laboratory science and clinical
application, and more generally, putting research-based
knowledge into practice [5, 7–9]. While translation in
the human sciences has emerged as a key theoretical
concept, which has problematised the complex inter-
faces of textual, cultural and material transgression and
exchange, its materialisation in medical discourse is of
an entirely different nature. In medicine, KT denotes a
scientific and purportedly non-cultural practice that
defines social and cultural differences as a ‘barrier’ to the
transmission of medical science. The aim of KT is to
bring pure scientific knowledge from ‘bench to bedside’
by testing its validity in clinical practice, while at the
same time keeping the scientific knowledge intact
throughout the process of translation across various
social fields and sectors of the healthcare system.
With few exceptions [5, 10], however, there has been
little theoretical reflection on translation as a process of
meaning production in KT. In this paper, we first argue
that KT is based on a simplistic view of translation and
knowledge dissemination, a view that to a large extent
takes translation as a phenomenon for granted. Second,
we maintain that the practice of KT might benefit from
incorporating more theoretical notions of translation as
an entangled material, textual and cultural process
which inevitably impacts the ‘original scientific message’.
The fact that translation has become a commonplace
(topos) in modern science with the ability to assemble an
array of divergent approaches and practices under one
name makes it a key instrument for transdisciplinary
translation and exchange. In this situation, concepts and
practices of translation have an unexploited potential for
bridging the gap between medicine and social/human
sciences. Such interdisciplinary exchange can, in turn,
contribute to an increased understanding of the inter-
play between scientific and cultural factors of KT and
thereby ultimately enhance the flow of knowledge within
healthcare. Hence, rather than dropping the KT meta-
phor, we should extend it by taking advantage of
discourses and practices of translation in the humanities.
Discussion
Translation in medicine
KT has generally been conceptualised in terms of a
chain involving distinct stages of production and dissem-
ination [9]. The most common current model comprises
three stages of translation, namely T1, a passage from
basic laboratory science to clinical research on popula-
tions (aka translational research); T2, from clinical
research to clinical recommendations, often in terms of
the development of clinical guidelines based on system-
atic reviews of clinical trials; and T3, from clinical
recommendations to routine clinical practice [7].
Here, translation is conceived of as a process of testing
and synthetising scientific knowledge produced in the la-
boratory to prepare it for sound clinical application and
scientifically warranted healthcare [11]. The underlying
assumption is that translation – if it is to be felicitous –
is non-productive. Its principal purpose is to preserve
and implement the original, scientific content in new
sociocultural contexts (practical healthcare in individual
cases across the globe). The influence of the ‘target cul-
ture’ (clinical practice) on the original (scientific) mes-
sage should be limited as far as possible. The
translational act itself is a non-act and the translator a
non-actor; the purpose of translation is to be a ‘con-
tainer’ of the original message without adding, trans-
forming or otherwise ‘betraying’ the original.
This presupposes that it is possible to separate the
production of knowledge from its transfer; the scientific
content to be translated is construed as being outside
the process of translation. The same distinction between
production and transfer is also inherent in the dominant
definition of KT as “exchange, synthesis and ethically-
sound application of knowledge” [8]. This definition
reduces the act of translation to activities (exchange,
synthesis and application) that are structurally and tem-
porally separate from the production of knowledge. In
line with this, so-called barriers and drivers of KT are
essentially understood as social and cultural factors
external to the production of knowledge [12]. Know-
ledge, moreover, is said to have reached its culmination
in the ‘secluded space’ of controlled trials, and it is the
results from these trials that should be transported to,
and implemented in, practical care situations. To accom-
plish this, various textual genres are mobilised in the dif-
ferent stages of the translation process, culminating in
so-called clinical guidelines, which prescribe manners of
intervention in concrete cases (e.g. particular diagnoses,
prognoses or treatments) based on systematic reviews of
the scientific state of the art. Hence, the translation
process hinges upon textualisation in such genres as sys-
tematic reviews and guidelines, and that such texts, in
increasingly condensed and vernacular forms, are able to
transmit the science necessary to implement state-of-
the-art care. The transference of the message from one
textual genre to another should not modify the scientific
content.
Translation as a textual and cultural supplement
The current construal of KT is actually close to the now
deeply compromised literary view of translation as a prac-
tice that aims at creating a semantic or pragmatic equiva-
lence between an original ‘source text’ and a new ‘target
text’ [13], a process governed by the norm of fidelity to
the source, and in which the translator’s work is ‘invisible’
[14] and merely ‘ancillary’ [15]. As emblematically
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formulated by Nabokov [16], “the person who desires to
turn a literary masterpiece into another language has only
one duty to perform, and this is to reproduce with absolute
exactitude the whole text, and nothing but the text”. How-
ever, more recent scholars in translation studies have
emphasised that the original source text can never be fully
recovered by the target text/culture, that translations al-
ways imply semantic shifts, and must be “rewritten in do-
mestic dialects and discourses, registers and styles” [17].
Besides, the importance of cultural factors has been
underscored. Lefevere [18] has, for instance, maintained
that problems in translation are not primarily of a linguis-
tic nature. Rather, questions of translatability have more
to do with cultural factors, what he refers to as “discrepan-
cies in the conceptual and textual grids”, than with “dis-
crepancies in languages” [18]. Interpreting the phrase
‘once upon a time’ as different from ‘a long time ago’, for
instance, requires knowledge of cultural genres. Such cul-
tural and textual framing cannot be read out of the sen-
tence as mere linguistic data. Linguistic translation, then,
also has to account for cultural factors, such as metadis-
cursive framings/practices, and different styles of reason-
ing [19].
According to Derrida [20], translation is an integral
part of all textual production; the translation or target
text relates to the source text as what Derrida has re-
ferred to as a “double supplement” – it both adds on to
the original and compensates for a lack in the original.
The translation does not only duplicate the original mes-
sage, it also completes the original message (‘the supple-
ment supplements’) by fulfilling one of its possible
interpretations. If, then, shifts of meaning are an inevit-
able outcome of the transport of signs between texts and
cultures, KT could become more effective if such shifts
were defined as a creative potential rather than as a
‘barrier’.
We maintain that KT relates to the ‘original scientific
content’ as a double supplement. On the one hand, KT
offers new approaches to the communication of scien-
tific knowledge to different groups in the healthcare sys-
tem with the aim of supplementing a lack of knowledge
among clinicians (and patients). On the other, it demon-
strates that a textual and cultural supplement, namely a
concern with target audiences (clinicians and patients),
is inevitable in the creation of an ‘autonomous’ science.
This creates an inherent paradox in existing KT models
– while these models presuppose that the principal duty
of adequate KT is to implement the original scientific
message in new social contexts and textual forms with-
out altering its content, the same models, paradoxically,
also state that it is through translational modifications
and adaption to new audiences, i.e. through synthesis
and development of guideline recommendations, that
the message becomes scientifically trustworthy. Hence,
translation both threatens and fulfils the original scien-
tific message. However, existing KT models fail to draw
the consequences from this paradox – translation is in-
herent in science and the division between science and
its translation is both impossible and unproductive to
maintain.
Practical implications: the case of pre-exposure prophy-
laxis (PrEP)
An illustrative example of this interdependency of sci-
ence and translation is the knowledge development
within HIV prevention. PrEP challenges the mere focus
on sexual behaviour change in HIV prevention, which is
considered to have been inadequate by most of the advo-
cates of the biomedicalisation of HIV prevention [21].
The principal preventive approaches developed over the
course of the first period in the fight against AIDS were
based on attempts to change behaviours, with the estab-
lishment of the social norm of safe sex and condom use
as a means of protection against HIV. The PrEP para-
digm is grounded on a different logic – bringing medica-
tion to the maximum number of people infected with
HIV will not only bring the promise of greatly enhanced
survival and quality of life for people living with HIV,
but will also greatly reduce their viral loads and the like-
lihood of passing the virus onto new people [22]. The
effectiveness of PrEP is backed by randomised controlled
trials (RCTs) demonstrating that medication provides
protection against the acquisition of HIV infection, if the
drug is taken regularly.
However, through their study design, the RCTs in
question control the social behaviour of the participants,
notably by including frequent HIV counselling and test-
ing during enrolment. In addition, behavioural interven-
tions (e.g. individualised motivational interviewing, risk-
reduction counselling) are used to assist participants in
overcoming obstacles to pill use [23]. The problem with
these studies is that they try to distinguish between the
scientific message and its translation to the target
culture while at the same time demonstrating their inter-
dependency; on the one hand, the RCT secludes the
intervention in a ‘controlled world’ independent of the
messiness of the social behaviour context that will
necessarily affect its translation into practice. On the
other hand, it is the same messiness of the social behav-
iour context that motivates the whole intervention;
sexual behaviour interventions are considered insuffi-
cient due to a lack of adherence in the target culture.
The RCT preconfigures an ‘ideal user’ who is taking the
medication regularly, a user that the same studies (by
introducing PrEP as a pharmaceutical supplement)
assume to be non-existent. The effect of the drug is
tested independently of the social dimensions that moti-
vated the intervention in the first place. Here, a paradox
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arises, namely if sexual behaviour interventions are now
regarded as inadequate – due to their reliance on a
human agent who is supposed to make right choices in
messy social contexts – PrEP actually assumes the very
same kind of agency and the ability of rationally choos-
ing in order to follow the PrEP regime.
Our point is that scientific evidence cannot be
obtained without acknowledging the active contribution
of particular target cultures and the creative potential of
KT. Understanding KT as a cultural and textual supple-
ment, as we suggest, is to acknowledge that altering the
scientific message is a necessary and integral part of KT.
Modifications and changes that occur through the trans-
lational process should therefore not be viewed as ‘bar-
riers’ to accurate translation; rather such changes are
prerequisites for evidence-based healthcare.
Conclusion
The linear conception of translation inherent in KT has
motivated researchers to abandon the metaphor and re-
place it with notions such as ‘co-creation’ or ‘transform-
ation’ [5]. We instead advocate that there is a theoretical
and practical potential in the concept of translation that
risks being lost with the introduction of a new termin-
ology. By searching to conceptualise the balance between
fidelity and creativity, between (scientific) content and
culture, and between technical and political consider-
ations, modern theories of translation can serve as an
‘epistemological lubricant’ [6] facilitating the transfer of
knowledge within healthcare, but also between medicine
and the human sciences. Such theories can lay the foun-
dation for an expanded model of KT that incorporates a
more dynamic conception of translation and a more
adequate and reflective description of the interdepend-
ency of scientific, cultural, textual and material practices.
This can, in turn, facilitate a better integration of
research evidence and knowledge developed within the
messy domain of ‘practice’, including both patient/user
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